<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
SCHEDULE 13G
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
UNIVEC, INC.
(Name of Issuer)
Common Stock, $.001 par value
------------------------------
(Title of Class of Securities)
91335U 10 8
------------------------------
(CUSIP Number)
<PAGE>
SCHEDULE 13G
_______________________________________________________________________________
CUSIP No. 91335U 10 8 Page 2 of 4
_______________________________________________________________________________
1 NAME OF REPORTING PERSON
S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. Alan H. Gold
______________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
______________________________________________________________________________
3 SEC USE ONLY
______________________________________________________________________________
4 CITIZENSHIP OR PLACE OR ORGANIZATION
U.S.A.
_______________________________________________________________________________
| |
NUMBER OF | 5 | SOLE VOTING POWER
SHARES | | 333,333
BENEFICIALLY |_____|________________________________________________________
OWNED BY | |
EACH | 6 | SHARED VOTING POWER
REPORTING | | None
PERSON WITH |_____|________________________________________________________
| |
| 7 | SOLE DISPOSITIVE POWER
| | 333,333
|_____|________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | None
_______________|_____|_________________________________________________________
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
333,333
______________________________________________________________________________
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
______________________________________________________________________________
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11.18%
______________________________________________________________________________
12 TYPE OF REPORTING PERSON
IN
______________________________________________________________________________
<PAGE>
_______________________________________________________________________________
CUSIP No. 91335U 10 8 Page 3 of 4
_______________________________________________________________________________
Item 1(a). Name of Issuer.
UNIVEC, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices.
999 Franklin Avenue, Garden City, New York 11530
.
Item 2(a). Name of Person Filing.
Dr. Alan H. Gold
Item 2(b). Address of Principal Business Office or, if None, Residence.
The Reporting Person's business address is c/o Long Island
Plastic Surgical Group, 999 Franklin Avenue, Garden City, New
York 11530.
Item 2(c). Citizenship.
USA.
Item 2(d). Title of Class of Securities.
Common Stock, par value $.001 per share.
Item 2(e). CUSIP Number.
91335U 10 8
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check
whether the person filing is a:
N/A
Item 4. Ownership.
(a) Amount Beneficially Owned: 333,333 shares of Common Stock.
(b) Percent of Class: 11.18%
(c) At December 31, 1997, the Reporting Person had sole voting
and dispositive power with respect to 333,333 shares of Common Stock.
<PAGE>
_______________________________________________________________________________
CUSIP No. 91335U 10 8 Page 4 of 4
_______________________________________________________________________________
Item 5. Ownership of Five Percent or Less of a Class.
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
N/A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certification.
N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 11, 1998
/s/ Dr. Alan H. Gold
----------------------------
Dr. Alan H. Gold
